Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kramer

Showing results (791-800 of 840) with videos related to

Pageof 84
Sort By:
Journal of Neurotrauma|October 27, 2020
Validity of the Brief Test of Adult Cognition by Telephone in Level 1 Trauma Center Patients Six Months Post-Traumatic Brain Injury: A TRACK-TBI StudyLindsay D Nelson, Jason K Barber, Nancy R Temkin, et al.
Science (New York, N.Y.)|May 30, 2015
Science and regulation. Congress's attacks on science-based rulesA A Rosenberg, L M Branscomb, V Eady, et al.
Science (New York, N.Y.)|August 1, 2015
Science in Congress: Deceptive statistics—ResponseAndrew A Rosenberg, L M Branscomb, V Eady, et al.
Alzheimer'S Research & Therapy|May 21, 2022
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
British Journal of Cancer|December 4, 1998
External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extractsC G Sweep, J Geurts-Moespot, N Grebenschikov, et al.
Alzheimer'S Research & Therapy|April 18, 2021
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 27, 2021
Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis"Eskild Petersen, Daniel Lucey, Lucille Blumberg, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2021
COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or ProphylaxisEskild Petersen, Daniel Lucey, Lucille Blumberg, et al.
Virus Evolution|July 26, 2019
Evolutionary dynamics and molecular epidemiology of <i>West Nile virus</i> in New York State: 1999-2015Sean M Bialosuknia, Yi Tan, Steven D Zink, et al.
Proceedings. Biological Sciences|February 23, 2022
Cellular and immunological mechanisms influence host-adapted phenotypes in a vector-borne microparasiteYi-Pin Lin, Danielle M Tufts, Matthew Combs, et al.
Pageof 84

Showing results (791-800 of 840) with videos related to

Sort By:
Pageof 84
Journal of Neurotrauma|October 27, 2020
Validity of the Brief Test of Adult Cognition by Telephone in Level 1 Trauma Center Patients Six Months Post-Traumatic Brain Injury: A TRACK-TBI StudyLindsay D Nelson, Jason K Barber, Nancy R Temkin, et al.
Science (New York, N.Y.)|May 30, 2015
Science and regulation. Congress's attacks on science-based rulesA A Rosenberg, L M Branscomb, V Eady, et al.
Science (New York, N.Y.)|August 1, 2015
Science in Congress: Deceptive statistics—ResponseAndrew A Rosenberg, L M Branscomb, V Eady, et al.
Alzheimer'S Research & Therapy|May 21, 2022
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
British Journal of Cancer|December 4, 1998
External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extractsC G Sweep, J Geurts-Moespot, N Grebenschikov, et al.
Alzheimer'S Research & Therapy|April 18, 2021
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 27, 2021
Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis"Eskild Petersen, Daniel Lucey, Lucille Blumberg, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2021
COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or ProphylaxisEskild Petersen, Daniel Lucey, Lucille Blumberg, et al.
Virus Evolution|July 26, 2019
Evolutionary dynamics and molecular epidemiology of <i>West Nile virus</i> in New York State: 1999-2015Sean M Bialosuknia, Yi Tan, Steven D Zink, et al.
Proceedings. Biological Sciences|February 23, 2022
Cellular and immunological mechanisms influence host-adapted phenotypes in a vector-borne microparasiteYi-Pin Lin, Danielle M Tufts, Matthew Combs, et al.
Pageof 84